Bloating, urgency, and food that suddenly disagrees.

The story is usually the same. Bloating that builds through the afternoon until a waistband feels tight. Urgency first thing in the morning, timed badly around the drive in or the first meeting. Foods eaten comfortably for decades, like onion, bread, coffee or a glass of red, now causing trouble. Nothing dramatic, just a gut that has stopped being something you can ignore.

It is common. A study of more than 73,000 adults across 33 countries found over 40% of online respondents met diagnostic criteria for at least one disorder of gut-brain interaction, and these conditions were linked to lower quality of life.¹ Common doesn’t mean trivial, and it doesn’t mean there is nothing to find. These symptoms have mechanisms, and in midlife the mechanism is usually recent.

The first question worth asking is when it started, and what else happened around then. The usual answers fall into four groups.

An infection. A bad bout of food poisoning or traveller’s diarrhoea can leave a lasting mark. A meta-analysis found more than 10% of people with infectious enteritis developed IBS afterwards, a risk about four times higher than people who hadn’t been unwell. Psychological distress at the time and antibiotic use during the illness raised the risk further.² The trip was often months earlier, so nobody connects the two.

A medication. Acid-suppressing drugs are among the most common long-term prescriptions in this age group. In a large Dutch population study, proton pump inhibitor users had measurably different gut bacteria, including more oral-type species reaching the bowel, and the effect at population level was larger than that of antibiotics.³

Load. The gut and brain are wired together through nerve, hormone and immune pathways, and chronic stress changes gut sensitivity, motility and barrier function.⁴ A hard year often shows up in the bowel well before anyone links the two.

Bile acids. Urgency that follows a richer meal, with loose stools early in the day, points somewhere specific. Across 18 studies, around a quarter to a third of people with diarrhoea-predominant IBS had bile acid malabsorption on SeHCAT scanning, and most of them responded to bile acid-directed management.⁵ It is under-recognised, and a microbiome report will not show it.

Some gut changes need proper investigation before anyone talks about bacteria. Blood in the stool, weight loss you didn’t intend, symptoms that wake you at night, iron deficiency, a family history of bowel cancer or inflammatory bowel disease, or a new and persistent change in bowel habit after 50 all belong in that group. They warrant investigation, which may include colonoscopy.

Two simple markers do a lot of sorting. Faecal calprotectin reflects inflammation in the bowel wall. In adults it picked up inflammatory bowel disease with 93% sensitivity and 96% specificity, and using it as a screen cut the number of people needing endoscopy by 67%.⁶ Coeliac serology is the other. People with IBS-type symptoms were more than four times as likely to have biopsy-proven coeliac disease as healthy controls.⁷ Coeliac disease can first appear in adulthood, and the blood test only works while you are still eating gluten. Cutting bread first and testing later is the most common way it gets missed.

A good stool panel earns its place. It can detect infections and parasites by PCR, measure inflammation, show how well fat and protein are being digested, and give a broad view of which bacteria are present and whether the groups that produce short-chain fatty acids are well represented. For how the different testing methods compare, see our guide to gut microbiome testing in Australia.

Its limits are just as real, and they are rarely printed on the report.

First, it cannot diagnose IBS. A systematic review of microbiome studies in IBS found some bacterial groups more common and others less common, but diversity was either lower or no different, and more than 40% of the studies did not report whether patients and controls were comparable. The authors could not say whether the changes caused IBS or resulted from it.⁸

Second, most reports give percentages rather than counts. A bacterial group can appear to fall simply because another one bloomed. When researchers measured actual bacterial load, total numbers varied widely between healthy people, and some patterns long treated as meaningful turned out to be artefacts of reporting percentages.⁹

Third, one sample reflects one day. Daily sampling of the same people over six weeks found that for 78% of bacterial groups, the swings within one person were larger than the differences between people, with shifts of up to 100-fold. Stool moisture was the biggest driver.¹⁰ A single result taken during a loose week and one taken during a settled week can look like two different guts.

None of this makes the test useless. It means the result is one piece of evidence, and it needs the others beside it.

The same stool report means different things in different people. Urgency with low ferritin and a positive coeliac antibody is one conversation. Urgency after rich meals with normal bloods and a clean calprotectin is another. Bloating that started three months after a gastro illness overseas is a third. The stool test is identical in all three. The rest of the picture is what separates them.

That picture is usually made of a few things: iron studies and B12, because absorption problems show up there first; coeliac serology, before any diet change; thyroid function, because it sets the pace of the bowel; the medication list, especially acid suppressants; and markers of load, such as sleep and the cortisol pattern, because a gut under sustained stress behaves differently. Then the timeline, which is often the most useful piece of evidence in the room.

Read that way, a microbiome result stops being a list of bacteria with arrows beside them. It becomes one data point in a question that can actually be answered: what changed, and what would change it back.